NCT05130307 is a NA clinical trial of virtual reality game in Pain, Acute, sponsored by University of Washington.

Who is sponsoring NCT05130307?

NCT05130307 is sponsored by University of Washington.

What drugs are being tested in NCT05130307?

Interventions in NCT05130307: virtual reality game.

What condition does NCT05130307 study?

NCT05130307 studies Pain, Acute.

Is NCT05130307 still recruiting?

NCT05130307 is currently completed. Last updated 24 August 2022.

Last reviewed 2022-08-24 · How we verify

NCT05130307

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality Analgesia for Brief Thermal Pain

Completed NA Last updated 24 August 2022

What this trial tests

NA trial testing virtual reality game in Pain, Acute in 48 participants. Completed in 3 June 2022.

Timeline

25 April 2022

Primary endpoint
3 June 2022

3 June 2022

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	48
Start date	25 April 2022
Primary completion	3 June 2022
Estimated completion	3 June 2022
Sites	1 location across United States

Drugs / interventions tested

virtual reality game

Conditions studied

Pain, Acute — all drugs for Pain, Acute →

Sponsor

University of Washington

Who can join

18 and older, any sex, with Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using immersive virtual reality as a form of pain distraction during a brief "painful but tolerable" temperature.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Adding tactile feedback increases avatar ownership and makes virtual reality more effective at reducing pain in a randomized crossover study.
Hoffman HG, Fontenot MR, Garcia-Palacios A, Greenleaf WJ, et al · · 2023 · cited 10× · PMID 37217536 · DOI 10.1038/s41598-023-31038-4

Verify or expand the search:

Other trials of virtual reality game

Trials testing the same drug.

NCT04268589 — Virtual Reality Effect in Geriatric Individuals · NA · completed

Other recruiting trials for Pain, Acute

Currently open trials in the same condition.

NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
NCT07053774 — Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain · Phase 2 · recruiting
NCT07009951 — Impact of Virtual Reality in Cardiac Electrophysiology · recruiting
NCT06960317 — Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements · NA · recruiting
NCT06754657 — CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery · Phase 4 · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05130307 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 24 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05130307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing